Skip to main content
. Author manuscript; available in PMC: 2022 Oct 17.
Published in final edited form as: Vaccine. 2022 May 14;40(26):3647–3654. doi: 10.1016/j.vaccine.2022.04.101

Fig. 2.

Fig. 2.

Countries where meningococcal B (MenB) vaccination in infants is routinely recommended nationwide (n = 14). For each country, the year of Bexsero® approval and the year of policy introduction are summarized, along with the recommended schedule and information on whether this vaccine is funded (i.e. provided free of charge) or provided for a fee. All data shown in this figure were obtained from publicly available country policy documents and/or from experts in the field.